结合或曲:通过基于NMR的形状测定来区分全性Abl激酶激活剂和对抗剂
Wolfgang Jahnke1, Robert M Grotzfeld, Xavier Pellé
1Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland. wolfgang.jahnke@novartis.com
Journal of the American Chemical Society
|May 11, 2010
概括
鉴定出了针对米里沙特口袋的新型Bcr-Abl抑制剂. 功能性活性取决于诱导_I中的特定形状变化,在慢性髓性白血病 (CML) 治疗中区分抗体和激动剂.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对Bcr-Abl的Allosteric抑制剂代表了慢性髓性白血病 (CML) 的有前途的治疗策略.
- 基于碎片的查被用来发现新型的Abl抑制剂结合于米里沙特口袋.
研究的目的:
- 为了研究myristate口袋连接体的功能活性.
- 为了确定Bcr-Abl抑制剂疗效的结构性决定因素.
- 开发一种测试方法,用于监测Abl的结构状态.
主要方法:
- 基于碎片的Abl抑制剂查.
- 基于NMR的构造试验,用于监测C端_I.I.
- 生物化学测定以确认c-Abl激活.
主要成果:
- 并非所有米里沙特口袋配体都是功能性的Bcr-Abl抑制剂.
- C-终端_I的构造状态是功能活动的关键决定因素.
- 诱导螺旋_I曲的配体是功能对抗剂;那些不诱导这种变化的配体是激酶对抗剂.
- 在生物化学上证实了c-Abl的Allosteric激素激活.
结论:
- 螺旋_I的构造状态决定了米里斯塔特口袋连接体结合的功能结果.
- 这种构造试验提供了一种方法来区分功能抗剂和激动剂.
- 了解这些机制可以指导开发更有效的CML疗法.
相关概念视频
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
The Equilibrium Binding Constant and Binding Strength
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...


